Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 1546 AL 1560

Telerehabilitation - Historical Perspectives and Conceptual Framework in Reference to Neurological Disorders: A Narrative Review

Olowoyo P, Dhamija RK, Owolabi MO.

NeuroRehabilitation. 2025 Feb;56(1):5-18. doi: 10.3233/NRE-240079. Epub 2025 Apr 4.

BDNF-TrkB Signaling in Mitochondria: Implications for Neurodegenerative Diseases

K Soman S, Swain M, Dagda RK.

Mol Neurobiol. 2025 Feb;62(2):1756-1769. doi: 10.1007/s12035-024-04357-4. Epub 2024 Jul 19.

Validation of the hotspot for dorsolateral subthalamic nucleus targeting in deep brain stimulation surgery for Parkinson's disease: a post hoc analysis of a randomised controlled trial

Bolier E, Holewijn R, De Bie RMA, Beudel M, van den Munckhof P, Schuurman R, Bot M.

J Neurol Neurosurg Psychiatry. 2025 Mar 13;96(3):272-279. doi: 10.1136/jnnp-2023-333164.

Quetiapine, Clozapine, and Pimavanserin Treatment Response in Monogenic Parkinson's Disease Psychosis: A Systematic Review

Colijn MA.

J Neuropsychiatry Clin Neurosci. 2025 Winter;37(1):6-13. doi: 10.1176/appi.neuropsych.20230231. Epub 2024 Jul 22.

Understanding the role of surgical intervention for patients with concomitant degenerative spinal disease without deformity and Parkinson's disease: a meta-analysis

Osborne-Grinter M, Copley P, Khan S, Kaliaperumal C.

Br J Neurosurg. 2025 Dec;39(6):798-806. doi: 10.1080/02688697.2024.2374581. Epub 2024 Jul 22.

Enteric neuroprotection-A matter of balancing redox potentials, limiting inflammation, and boosting resilience

Voss U.

Neurogastroenterol Motil. 2025 Aug;37(8):e14871. doi: 10.1111/nmo.14871. Epub 2024 Jul 22.

Patterns, outcomes, and preventability of clinically manifest drug-drug interactions in older outpatients: a subgroup analysis from a 6-year-long observational study in North India

Kaur U, Reddy J, Reddy NTS, Gambhir IS, Yadav AK, Chakrabarti SS.

Naunyn Schmiedebergs Arch Pharmacol. 2025 Jan;398(1):687-698. doi: 10.1007/s00210-024-03294-2. Epub 2024 Jul 24.

Corrigendum: Modeling Parkinson's Disease in Primates

Bezard E, Teil M, Arotcarena ML, Porras G, Li Q, Dehay B.

Cold Spring Harb Perspect Med. 2025 Feb 3;15(2):a041802. doi: 10.1101/cshperspect.a041802.

Outcome of Drug-Induced Parkinsonism in the Elderly: A Permanent Nonprogressive Parkinsonian Syndrome May Occur Following Discontinuation of Cinnarizine and Flunarizine

Calzetti S, Negrotti A.

Ann Pharmacother. 2025 Mar;59(3):289-293. doi: 10.1177/10600280241263592. Epub 2024 Jul 25.

Association between chemokine genes polymorphisms and susceptibility to Parkinson's disease: a meta-analysis and systematic review

Lee YH, Song GG.

Acta Neurol Belg. 2025 Jun;125(3):599-607. doi: 10.1007/s13760-024-02615-9. Epub 2024 Jul 27.

AQuaRef: Machine learning accelerated quantum refinement of protein structures

Zubatyuk R, Biczysko M, Ranasinghe K, Moriarty NW, Gokcan H, Kruse H, Poon BK, Adams PD, Waller MP, Roitberg AE, Isayev O, Afonine PV.

bioRxiv [Preprint]. 2025 Apr 5:2024.07.21.604493. doi: 10.1101/2024.07.21.604493.

Correction to: Noradrenergic cardiac denervation is associated with gait velocity in Parkinson disease: a dual ligand PET study

Carli G, Kanel P, Roytman S, Pongmala C, Albin RL, Raffel DM, Scott PJH, Bohnen NI.

Eur J Nucl Med Mol Imaging. 2025 Mar;52(4):1596-1599. doi: 10.1007/s00259-024-06839-y.

Alzheimer's Disease and Vascular Dementia, Connecting and Differentiating Features

Hurla M, Banaszek N, Kozubski W, Dorszewska J.

Curr Alzheimer Res. 2025;22(1):2-18. doi: 10.2174/0115672050319219240711103459.

Naringenin: A Promising Immunomodulator for Anti-inflammatory, Neuroprotective and Anti-cancer Applications

Solanki S, Vig H, Khatri N, Singh BP, Khan MS, Devgun M, Wal P, Wal A.

Antiinflamm Antiallergy Agents Med Chem. 2025;24(1):1-25. doi: 10.2174/0118715230320007240708074939.

Acquired chronic hepatocerebral degeneration (CAHD) - Simulation of parkinsonism, secondary to chronic liver disease

Fernández Carrasco M, Sánchez García O, Plaza Fernández A.

Rev Esp Enferm Dig. 2025 Oct;117(10):600-601. doi: 10.17235/reed.2024.10535/2024.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias